Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs

Allergen immunotherapy (AIT) is the only treatment option available for allergic patients with disease-modifying intention. Both efficacy and safety has been demonstrated for multiple trials in children, adolescents and adults. Though regulatory requirements for marketing authorization have been cle...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaar, O., Gerth van Wijk, R., Klimek, L., Bousquet, J., Creticos, P. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181492/
https://www.ncbi.nlm.nih.gov/pubmed/32346471
http://dx.doi.org/10.1186/s13601-020-00314-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181492/
https://www.ncbi.nlm.nih.gov/pubmed/32346471
http://dx.doi.org/10.1186/s13601-020-00314-1

Ejemplares similares